Recall: Semglee
Feb. 2022Pharmacy Updates
Mylan Pharmaceuticals Inc., a Viatris company, is recalling a batch of Semglee® (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens, which are packaged in a labeled carton of five pens. Read the full text of the Semglee recall.
Recent Announcements
Watch for a chance to rate your experience with UPMC Health Plan
Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.Aug. 2026Important Notices
Voluntary nationwide recall: Cetirizine (Unique – July)
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.Jul. 2026Pharmacy Updates
August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates
Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.Jul. 2026Pharmacy Updates